COMMUNIQUÉS West-GlobeNewswire
-
Atrion Corporation Declares Quarterly Cash Dividend
27/02/2018 - 20:31 -
Vital® to Showcase Enhancements to the Vitrea® Enterprise Imaging Solution at HIMSS 2018
27/02/2018 - 19:45 -
Micron Solutions, Inc. Announces Multi-Year Exclusive Manufacturing Agreement with its Largest Customer
27/02/2018 - 18:21 -
Helsinn Group announces the appointment of Paul Rittman as Chief Executive Officer, Helsinn Therapeutics (HTU)
27/02/2018 - 18:00 -
Dentsply Sirona to Report Fourth Quarter and Fiscal 2017 Results
27/02/2018 - 18:00 -
AllSpire Health GPO Adopts Lumere’s Solutions to Support Value-Based Initiatives
27/02/2018 - 17:59 -
Les infirmières et les infirmiers du Canada accueillent favorablement les nouvelles au sujet d’un groupe de travail national sur la mise en place d’un régime d’assurance-médicaments
27/02/2018 - 17:38 -
RAMSAY GENERALE DE SANTE : Half-year Results at the end of December 2017
27/02/2018 - 17:36 -
RAMSAY GENERALE DE SANTE : Résultats semestriels à fin décembre 2017
27/02/2018 - 17:36 -
The EMA Grants Accelerated Assessment for Shire's Lanadelumab Being Evaluated for the Prevention of Attacks in HAE Patients Aged 12 Years and Older
27/02/2018 - 17:19 -
SteroTherapeutics Announces Closing of Financing to Accelerate Clinical Study for Non-Alcoholic Steatohepatitis (NASH)
27/02/2018 - 16:52 -
Canada’s nurses welcome reports of a federal pharmacare task force
27/02/2018 - 16:40 -
Novo Nordisk files for regulatory approval of long-acting factor VIII (N8-GP) in the US and the EU for treatment of haemophilia A
27/02/2018 - 16:10 -
Vizient, Inc. Awards National Contract to PDC Healthcare for Patient ID Bands
27/02/2018 - 16:00 -
Scapa Healthcare Unveils Three R&D Centers of Excellence in U.S. and Europe for Development of Innovative, Turn-key, Skin-Friendly Solutions
27/02/2018 - 16:00 -
Intellia Therapeutics Announces Publication in Cell Reports of Preclinical Data Demonstrating Effective CRISPR/Cas9 Genome Editing Using Lipid Nanoparticle (LNP) Delivery Technology
27/02/2018 - 15:28 -
Voyager Therapeutics to Host Fourth Quarter and Full Year 2017 Financial Results and Corporate Highlights Conference Call
27/02/2018 - 15:17 -
PCI Synthesis Celebrates Key Milestones Including 4th Consecutive Year of Double-Digit Growth, 2 Commercial Approvals and a New Office in San Diego
27/02/2018 - 15:15 -
Aptevo Therapeutics to Present at the 30th Annual ROTH Conference
27/02/2018 - 15:02
Pages